237 related articles for article (PubMed ID: 12853838)
1. Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer.
Chang LL; Yeh WT; Yang SY; Wu WJ; Huang CH
J Urol; 2003 Aug; 170(2 Pt 1):595-600. PubMed ID: 12853838
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma.
Xing EP; Nie Y; Song Y; Yang GY; Cai YC; Wang LD; Yang CS
Clin Cancer Res; 1999 Oct; 5(10):2704-13. PubMed ID: 10537333
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between alterations of p16INK4a and p14ARF genes of CDKN2A locus and gastric carcinogenesis].
Tang SH; Yang DH; Luo HS; Yu JP; Shu JC
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):517-21. PubMed ID: 15231134
[TBL] [Abstract][Full Text] [Related]
4. Alterations of p14ARF and p16INK4a genes in salivary gland carcinomas.
Nishimine M; Nakamura M; Kishi M; Okamoto M; Shimada K; Ishida E; Kirita T; Konishi N
Oncol Rep; 2003; 10(3):555-60. PubMed ID: 12684623
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of tumor suppressor genes, Rb, p53, p16INK4A, p15INK4B and p14ARF in natural killer cell neoplasms.
Sakajiri S; Kawamata N; Egashira M; Mori K; Oshimi K
Jpn J Cancer Res; 2001 Oct; 92(10):1048-56. PubMed ID: 11676855
[TBL] [Abstract][Full Text] [Related]
6. Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms.
Silva J; Silva JM; Domínguez G; García JM; Cantos B; Rodríguez R; Larrondo FJ; Provencio M; España P; Bonilla F
J Pathol; 2003 Mar; 199(3):289-97. PubMed ID: 12579530
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status.
Esteller M; Tortola S; Toyota M; Capella G; Peinado MA; Baylin SB; Herman JG
Cancer Res; 2000 Jan; 60(1):129-33. PubMed ID: 10646864
[TBL] [Abstract][Full Text] [Related]
8. Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR.
Berggren P; Kumar R; Sakano S; Hemminki L; Wada T; Steineck G; Adolfsson J; Larsson P; Norming U; Wijkström H; Hemminki K
Clin Cancer Res; 2003 Jan; 9(1):235-42. PubMed ID: 12538475
[TBL] [Abstract][Full Text] [Related]
9. Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma.
Ohta S; Uemura H; Matsui Y; Ishiguro H; Fujinami K; Kondo K; Miyamoto H; Yazawa T; Danenberg K; Danenberg PV; Tohnai I; Kubota Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jan; 107(1):81-91. PubMed ID: 19101490
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation and homozygous deletion of the p14ARF and p16INK4a genes in oligodendrogliomas.
Watanabe T; Nakamura M; Yonekawa Y; Kleihues P; Ohgaki H
Acta Neuropathol; 2001 Mar; 101(3):185-9. PubMed ID: 11307615
[TBL] [Abstract][Full Text] [Related]
11. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer.
Burri N; Shaw P; Bouzourene H; Sordat I; Sordat B; Gillet M; Schorderet D; Bosman FT; Chaubert P
Lab Invest; 2001 Feb; 81(2):217-29. PubMed ID: 11232644
[TBL] [Abstract][Full Text] [Related]
12. p14ARF deletion and methylation in genetic pathways to glioblastomas.
Nakamura M; Watanabe T; Klangby U; Asker C; Wiman K; Yonekawa Y; Kleihues P; Ohgaki H
Brain Pathol; 2001 Apr; 11(2):159-68. PubMed ID: 11303791
[TBL] [Abstract][Full Text] [Related]
13. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylations of p16INK4a and p14ARF genes in early and advanced gastric cancer. Correlations of the modes of their occurrence with histologic type.
Tsujimoto H; Hagiwara A; Sugihara H; Hattori T; Yamagishi H
Pathol Res Pract; 2002; 198(12):785-94. PubMed ID: 12608655
[TBL] [Abstract][Full Text] [Related]
15. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors.
Dominguez G; Silva J; Garcia JM; Silva JM; Rodriguez R; Muñoz C; Chacón I; Sanchez R; Carballido J; Colás A; España P; Bonilla F
Mutat Res; 2003 Sep; 530(1-2):9-17. PubMed ID: 14563526
[TBL] [Abstract][Full Text] [Related]
17. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
[TBL] [Abstract][Full Text] [Related]
18. p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma.
Hirabayashi H; Fujii Y; Sakaguchi M; Tanaka H; Yoon HE; Komoto Y; Inoue M; Miyoshi S; Matsuda H
Int J Cancer; 1997 Nov; 73(5):639-44. PubMed ID: 9398039
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer.
Lee M; Sup Han W; Kyoung Kim O; Hee Sung S; Sun Cho M; Lee SN; Koo H
Pathol Res Pract; 2006; 202(6):415-24. PubMed ID: 16675157
[TBL] [Abstract][Full Text] [Related]
20. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]